• AI Maverick Intel issued 76,500,000 common shares to HEAL Group Holdings as an initial tranche of consideration under a right-of-first-refusal agreement tied to a proposed acquisition of HEAL Access Canada.
• The share consideration for the transaction was revised to 100,000,000 AIMV common shares from 120,000,000 as the parties move toward a definitive agreement for AIMV to acquire 100% of HEAL Access Canada.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ai Maverick Intel Inc. published the original content used to generate this news brief via ACCESS Newswire (Ref. ID: 202605121000ACCESSWRNAPR_____1166133) on May 12, 2026, and is solely responsible for the information contained therein.